图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
免疫学评论综述™
影响因子: 1.352 5年影响因子: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN 打印: 1040-8401
ISSN 在线: 2162-6472

免疫学评论综述™

DOI: 10.1615/CritRevImmunol.v29.i3.50
pages 255-273

Traditional Concepts and Future Avenues of Glucocorticoid Action in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis Therapy

Fred Luhder
Institute for Multiple Sclerosis Research, University of Göttingen and Gemeinnützige Hertie-Stiftung, Waldweg 33, 37073 Göttingen, Germany
Holger Reichardt
Institute of Cellular and Molecular Immunology, University of Goettingen Medical School

ABSTRACT

Glucocorticoids (GCs) constitute one of the oldest families of anti-inflammatory and immunosuppressive drugs. Since their first clinical use more than half a century ago, they have been employed for therapeutic invention in a variety of conditions, including atopic disorders, autoimmune diseases, and cancer. Nevertheless, their exact mechanism of action is still incompletely understood. In this review, we elaborate especially on the mechanism of GCs in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), and summarize our current knowledge on how therapeutic and endogenous GCs impact the pathogenesis of EAE and MS. This includes findings obtained from genetically modified mice and rats lacking or overexpressing the GC receptor (GR) in specific cell types, and the analysis of new pharmaceutical formulations and chemical GC modifications aimed at improving treatment efficacy and specificity. Stimulated by these recent developments, it can be anticipated that novel therapeutic regimens will find their way into clinical practice for the benefit of affected patients.


Articles with similar content:

Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases
Critical Reviews™ in Immunology, Vol.33, 2013, issue 5
Paul J. Bryce, Charles B. Smarr, Stephen D. Miller
Autoimmune Pathogenesis of Multiple Sclerosis: Role of Autoreactive T Lymphocytes and New Immunotherapeutic Strategies
Critical Reviews™ in Immunology, Vol.17, 1997, issue 1
Piet Stinissen, Jef Raus, Jingwu Zhang
Which Immune Cells Matter? The Immunopathogenesis of Multiple Sclerosis
Critical Reviews™ in Immunology, Vol.33, 2013, issue 4
Bieke Broux, Piet Stinissen, Niels Hellings
Transcription Factors and Th17 Cell Development in Experimental Autoimmune Encephalomyelitis
Critical Reviews™ in Immunology, Vol.33, 2013, issue 2
Guobing Chen, M. Frances Shannon
Gut Microbiota: Potential Impact on Chemotherapy-Related Adverse and Therapeutic Effects
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
M. Salimon, E. Montassier, Yann Touchefeu